According to a new study, Food & Drug Administration (FDA) advisors don’t say no very often when deciding to recommend a drug or approve a new medical device. The FDA counts on the committees for safety feedback and the study raises serious questions about their independence.
The Food and Drug Administration (FDA) ordered strong warnings to be put on the labels of stimulants used to treat attention deficit disorder and hyperactivity. The labels warn about their use in children and adults with heart problems, and to make doctors aware that one in a thousand children may experience hallucinations.
During the past few years, over 6,000 lawsuits have been filed against four major drugs claiming their makers failed to disclose the drugs’ risks or failed to properly test them. Lawsuits like these are raising concerns about whether drugmakers and the Food and Drug Administration (FDA) care about patient safety.
Nobody denies the link between the powerful acne drug Accutane and an increase in birth defects. But a recent study found the drug also raised the risk for a potential heart attack or liver problem.
In the ninth trial of its kind, a federal jury ordered drug manufacturer Vioxx to pay $51 million to Gerald Barnett, who had a heart attack after taking Vioxx for over four years.
With children headed back to the classroom, Edgar Snyder & Associates wants to make sure your kids travel safely. The following back-to-school safety tips will help prevent accidents as children return to the hallways of elementary, middle, and high schools across the country.
The Food & Drug Administration (FDA) ordered Bausch & Lomb to pull its ReNu MoistureLoc contact solution from the shelves due to a link with a serious eye infection. Note that some dollar stores are still selling the product.
The Food and Drug Administration (FDA) has decided to tackle pharmacies that mass-produce unapproved copies of brand-name drugs. The first set of warnings was sent out to three large pharmacies notifying them that they were in violation of federal law for producing liquid drugs inhaled by respiratory patients who use nebulizers.
Following the lead of Triaminic’s vapor patch recall, Mentholatum Company has voluntarily recalled their WellPatch Cough & Cold Soothing Vapor Pads. The WellPatch vapor pads were recalled for potentially serious health risks that could result if the patch is ingested, the same reason why the Triaminic vapor pads were recalled.